Navigation Links
New studies on schizophrenia, depression, trauma and autism highlight annual meeting
Date:12/3/2007

WHAT: The 2007 American College of Neuropsychopharmacology Annual Meeting will feature hundreds of new studies on brain and behavior from the worlds leading scientists. Presentations include innovative research on potential new treatments for depression, post-traumatic stress disorder, autism and addiction.

SELECTED PANELS INCLUDE:

  • Study Finds Genetic Link between Cancer and Schizophrenia A series of studies elucidates evidence that there is a genetic link between schizophrenia and cancer, providing a surprising possible scientific explanation for lower rates of cancer among patients with schizophrenia despite having poor diets and high rates of smoking and their parents. (Embargoed until 9:00 a.m. EST December 8)

  • Research Finds Link between Depression and Heart Disease Depression nearly triples the risk of death following a heart attack, even when accounting for other heart attack risk factors, according to research which showed that among 360 depressed, post myocardial infarction patients followed for more than six years, those who did not recover from their depression in the first six months were more than twice as likely to die. (Embargoed until 9:00 a.m. EST December 8)

  • Study Shows Psychotherapy Helpful in Treating Post-Traumatic Stress Disorder in Early Stages When treated within a month, survivors of a psychologically traumatic event improved significantly with psychotherapy. Researchers studied 248 adults with early symptoms of post-traumatic stress disorder (PTSD) following a traumatic event that had occurred no more than four weeks earlier. (Embargoed until 9:00 a.m. EST December 8)

  • New Studies Suggest Brain Overgrowth in One-Year-Olds Linked to Development of Autism Brain overgrowth in the latter part of an infants first year may contribute to the onset of autistic characteristics. These findings support concurrent research which has found brain overgrowth in autistic children as young as two years old. (Embargoed until 9:00 a.m. EST December 8)

  • Study Finds First-Ever Genetic Animal Model of Autism By introducing a gene mutation in mice, investigators have created what they believe to be the first accurate model of autism not associated with a broader neuropsychiatric syndrome. This animal model could help researchers better understand abnormal brain function in autistic humans, which could help them identify and improve treatment strategies. (Embargoed until 9:00 a.m. EST December 8)

  • Study Shows New Strategy for Developing Rapid-Acting Antidepressants Researchers may be able to develop an antidepressant which takes effect almost immediately by directly targeting novel molecules in the brain instead of taking a less direct route, which can lead to longer times for medication to take effect. (Embargoed until 9:00 a.m. EST December 8)

  • Study Finds Brain Differences in Adolescents with Mental Illness Puberty may have an impact on areas of the brain that contribute to bipolar disorder or schizophrenia in youth, according to new research. Investigators found size difference in the brains of youth with bipolar disorder and schizophrenia, which could help identify different treatment approaches in boys and girls. (Embargoed until 9:00 a.m. EST December 8)

  • Nicotine Addiction Might be Controlled by Influencing Pleasurable Response Mechanisms in Brain There is a clear link between GABA a chemical substance of the central nervous system that inhibits neurons in the brain and nicotine dependence. Researchers discovered that nicotine has significant effects on brain GABA, a finding which could potentially help curb the pleasurable effects of nicotine and help people break their addiction to it. (Embargoed until 9:00 a.m. EST December 8)

  • Stable Sleep Patterns and Regular Routines May Improve Outcomes in Bipolar Disorder Bipolar disorder, commonly known as manic-depressive disorder, is highly influenced by the circadian system the bodys internal clock and a specific kind of psychotherapy may help decrease irregularities in the circadian system that can trigger key symptoms of bipolar disorder (Embargoed until 9:00 a.m. EST December 8)

WHO: ACNP, founded in 1961, is a professional organization of more than 700 leading scientists, including three Nobel Laureates. The mission of ACNP is to further research and education in neuropsychopharmacology and related fields in the following ways: promoting the interaction of a broad range of scientific disciplines of brain and behavior in order to advance the understanding of prevention and treatment of disease of the nervous system including psychiatric, neurological, behavioral and addictive disorders; encouraging scientists to enter research careers in fields related to these disorders and their treatment; and ensuring the dissemination of relevant scientific advances. A non-profit organization, ACNP receives revenues from a variety of sources including membership dues, publication sales, registration fees, and pharmaceutical industry grants.

WHEN: December 8-12, 2007, Boca Raton, Florida


'/>"/>

Contact: Amy Levery
alevey@gymr.com
202-745-5116
American College of Neuropsychopharmacology
Source:Eurekalert

Related biology news :

1. Claims of sex-related differences in genetic association studies often not properly validated
2. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
3. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
4. Studies: Children obese due to a host of unhealthy pressures
5. Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients
6. LSU professor studies army-ant-following birds
7. 2 carotid artery stenting studies show results comparable to AHA guidelines
8. NIH grants enable energy studies
9. Depression, aging, and proteins made by a virus may all play role in heart disease
10. Asthma link to post-traumatic stress disorder, says Mailman School of Public Health study
11. Club drugs inflict damage similar to traumatic brain injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ON , June 27, 2016 /PRNewswire/ - BIOREM Inc. ... has been advised by its major shareholders, Clean Technology ... United States based venture capital ... shares of Biorem (on a fully diluted, as converted ... the disposition of their entire equity holdings in Biorem ...
(Date:6/27/2016)... ... , ... Parallel 6 , the leading software as a service (SaaS) ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication between ... Using the CONSULT module, patients and physicians can schedule a face to face virtual ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
Breaking Biology Technology: